Want to see IN:SHALBY full AI Analyst Report?
SHALBY Stock Chart & Stats
₹202.80
-₹4.08(-1.73%)
At close: 4:00 PM EST
₹202.80
-₹4.08(-1.73%)
Day’s Range― - ―
52-Week Range₹125.70 - ₹274.50
Previous CloseN/A
Volume74.36K
Average Volume (3M)71.31K
Market Cap
₹18.62B
Enterprise Value₹24.14B
Total Cash (Recent Filing)₹1.31B
Total Debt (Recent Filing)₹5.35B
Price to Earnings (P/E)53.1
Beta1.24
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.59%
Share Statistics
EPS (TTM)0.19
Shares Outstanding108,009,766
10 Day Avg. Volume22,132
30 Day Avg. Volume71,313
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.46
Price to Sales (P/S)1.29
P/FCF Ratio-8.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4
Revenue Forecast (FY)₹11.94B
Bulls Say, Bears Say
Bulls Say
Specialized Hospital Chain & Orthopaedics FocusShalby’s core business is a multi‑specialty hospital network with a clear clinical focus on orthopaedics and joint replacement. That specialization creates durable procedure demand, referral flows and ancillary revenue streams (diagnostics, pharmacy) that support steady utilization and pricing power over time.
Sustained Top-line GrowthMulti‑year revenue growth more than doubled the top line over five years, indicating successful capacity expansion and market penetration. Persistent volume growth supports scale economics, network effects and long‑term service availability despite near‑term margin variation.
Equity Capital CushionReported equity remaining broadly stable gives Shalby a material capital buffer to absorb operational volatility and fund strategic investments. A stable equity base supports hospital operations and provides longer‑term solvency resilience while management addresses cash generation and leverage.
Bears Say
Negative Operating And Free Cash FlowTwo consecutive years of negative operating and free cash flow indicate the business is consuming cash, increasing reliance on external funding. This undermines internal financing for capex and working capital, elevates refinancing and execution risk for network expansion or debt repayment over the medium term.
Rising Financial LeverageA marked increase in leverage reduces financial flexibility and raises interest‑coverage and refinancing pressures. For a hospital operator with negative cash generation, higher debt amplifies funding risk and could constrain strategic choices, especially if operating performance does not stabilize.
Margin Erosion And Volatile ProfitabilityDeclining gross and net margins and material earnings volatility signal weakening operational efficiency and pricing power. Lower margins reduce the company’s ability to convert revenue growth into returns, leaving ROE modest and limiting internal funds to repair cash flow or service higher debt.
Shalby Ltd. News
SHALBY FAQ
What was Shalby Ltd.’s price range in the past 12 months?
Shalby Ltd. lowest stock price was ₹125.70 and its highest was ₹274.50 in the past 12 months.
What is Shalby Ltd.’s market cap?
Shalby Ltd.’s market cap is ₹18.62B.
When is Shalby Ltd.’s upcoming earnings report date?
Shalby Ltd.’s upcoming earnings report date is Aug 10, 2026 which is in 36 days.
How were Shalby Ltd.’s earnings last quarter?
Shalby Ltd. released its earnings results on May 27, 2026. The company reported ₹1.72 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.72.
Is Shalby Ltd. overvalued?
According to Wall Street analysts Shalby Ltd.’s price is currently Overvalued.
Does Shalby Ltd. pay dividends?
Shalby Ltd. pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.59%. See more information on Shalby Ltd. dividends here
What is Shalby Ltd.’s EPS estimate?
Shalby Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shalby Ltd. have?
Shalby Ltd. has 108,009,766 shares outstanding.
What happened to Shalby Ltd.’s price movement after its last earnings report?
Shalby Ltd. reported an EPS of ₹1.72 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.606%.
Which hedge fund is a major shareholder of Shalby Ltd.?
Currently, no hedge funds are holding shares in IN:SHALBY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shalby Ltd.
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―